EDTA with R-Lipoic Acid - Quicksilver Scientific - Dr Chris Shade

Liposomal EDTA w/ R-Lipoic Acid is a highly absorbable form of oral EDTA. 

The absorption of conventional oral EDTA (tablets or capsules) is less than 5%.1 CaNa2 EDTA, traditionally used for intravenous (IV) injection, is distributed mainly in the extracellular fluids, which limits its capacity to act inside the cell. Without the ability to transport across physiological barriers into compartments where biological processes take place and compounds such as EDTA interact with metals, therapies are ineffective. Nano-sized liposomal delivery systems are highly absorbed orally, with the very small liposomes allowing for intracellular delivery of their encapsulated contents. For some compounds, this can lead to higher intracellular delivery than is possible even with an IV.2
Quicksilver Delivery Systems™ brings the power of intravenous therapy into convenient oral delivery.

Quicksilver Delivery Systems™ improve upon liposomal and emulsification technology with smaller, more stable particles made from the highest-grade ingredients available. In addition to exceptional absorption rates, these very small liposomal and nanoemulsified particles enhance lymphatic circulation of nutrients and intracellular delivery.3,4 The phospholipids, inherent in the liposomal and nanoemulsified formats, nourish cell membranes, promoting proper function for the absorption of nutrients and the excretion of cellular waste products and toxins.* 5

Production Technology Features: 

• Tightly controlled small sizing, verified by Laser Dynamic Light Scattering on each batch (particle mean size 50-100nm) 

• Pleasant taste, suitable for intra-buccal delivery for best systemic availability 

• May be dispersed in water or other liquid when desired

Delivered with EDTA, the antioxidant R-lipoic acid (as sodium R-lipoate) supports endogenous production of glutathione, an integral component of detoxification, as well as metal mobilization and recovery.3